as on January 21, 2026 at 4:01 pm IST
Day's Low
Day's High
5.69%
Downside
0.34%
Upside
52 Week's Low
52 Week's High
50.04%
Downside
5.65%
Upside
as on January 21, 2026 at 4:01 pm IST
Market Cap
₹935.72 Cr
Return on Equity (ROE)
6.39
PE Ratio (TTM)
47.36
Return on capital employed (ROCE)
8.37
Industry PE ratio
40.06
Beta (LTM)
0.65
P/B Ratio
1.64
Dividend Yield
0PEG Ratio
14.94
Quarterly Earnings Growth YOY
-5.42
EPS (TTM)
7.97
Sector
Pharmaceuticals
Book Value
128.75
Technical Analysis
Bullish
View Technical Analysis
as on January 21, 2026 at 4:01 pm IST
Sakar Healthcare in the last 5 years
Lowest (13.06x)
May 12, 2022
Industry (40.06x)
January 21, 2026
Today (47.36x)
January 21, 2026
Highest (71.76x)
January 24, 2024
Today’s Price to Earnings Ratio: 47.36x
Compare market cap, revenue, PE, and other key metrics of Sakar Healthcare with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 935.72 | 55.64% | 0.62 | 17 | 177 | |
| BUY | 3,051.12 | -2.35% | 0.53 | 133 | 636 | |
| NA | 1,669.53 | 18.91% | 0.53 | 60 | 759 | |
| NA | 81.11 | -11.3% | 0.00 | 10 | 40 | |
| NA | 3,129.82 | 32.97% | 0.69 | 69 | 819 |
Get share price movements and forecasts by analysts on Sakar Healthcare.
Source: S&P Global Market Intelligence
Search interest for Sakar Healthcare Ltd Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Sakar Healthcare.
Sakar Healthcare Ltd’s net profit fell -5.42% since last year same period to ₹4.54Cr in the Q2 2025-2026. On a quarterly growth basis, Sakar Healthcare Ltd has generated -2.78% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 6 quarters, 41.61 Cr → 58.78 Cr (in ₹), with an average increase of 6.6% per quarter
Price Rise
![]()
In the last 3 months, SAKAR stock has moved up by 12.0%
Best in 1 Year
![]()
In the last 1 year, SAKAR has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 52.86% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 148.9% return, outperforming this stock by 87.9%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 13.41% to 13.31% in Sep 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 22.48% to 22.41% in Sep 2025 quarter
Profit Down
![]()
Netprofit is down for the last 3 quarters, 5.76 Cr → 4.54 Cr (in ₹), with an average decrease of 10.9% per quarter
| Organisation | Sakar Healthcare Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| CEO | Sanjay S Shah. |
| E-voting on shares | Click here to vote |
Sakar Healthcare share price today stands at ₹420.55 as on at the close of the market. Sakar Healthcare share today touched a day high of ₹422 and a low of ₹396.6.
Sakar Healthcare touched a 52 week high of ₹444.3 and a 52 week low of ₹210.1. Sakar Healthcare share price today i.e. is closed at ₹420.55, which is -5.35% down from its 52 week high and 100.17% up from its 52 week low.
Sakar Healthcare market capitalisation is ₹935.72 Cr as on .
To buy Sakar Healthcare shares, you need to follow these steps:
Sakar Healthcare trading volume is 46.47K as on . This means that 46.47K shares of Sakar Healthcare were bought and sold on the stock market during today's trading session.